NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

Biotechnology

Healthcare
$2.55 +1.43%

+$0.06 today

Market cap
$113.04M
Beta
2.19
P/E (TTM)
-5.3
EPS (TTM)
-$0.76
52W Low $1.62High $5.06

Volume 1.39M

Average 1.27M

Balance Sheet

Inspect the capital base behind the business.

Assets

$12.96M

FY 2025 · Annual

+254.9% YoY

Liabilities

$28.89M

FY 2025 · Annual

+7.5% YoY

Equity

-$15.94M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents27.61M20.05M4.6M1.44M7.8M
Short-term Investments00000
Net Receivables07K6K0161K
Inventory00000
Other Current Assets00000
Total Current Assets32.71M25.8M6.88M3.3M8.89M
Property, Plant & Equipment (Net)0000633K
Goodwill00001.79M
Intangible Assets0000925K
Long-term Investments0000397K
Tax Assets00000
Other Non-current Assets15K21K431K349K316K
Total Non-current Assets15K21K431K349K4.06M
Total Assets32.73M25.82M7.32M3.65M12.96M
Account Payables3.69M2.08M4.63M4.13M4.27M
Short-term Debt518K7.7M9.16M1.57M0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities4.87M37K4.42M10.93M18.31M
Total Current Liabilities11.92M15.59M19.05M21.86M28.58M
Long-term Debt02.82M05.01M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities02.82M05.01M315K
Total Liabilities11.92M18.41M19.05M26.87M28.89M
Common Stock59K67K84K15K32K
Retained Earnings(183.24M)(223M)(253.15M)(278.27M)(306.9M)
Accumulated OCI00(3K)00
Other Stockholders Equity00000
Minority Interest00000
Total Equity20.81M7.41M(11.73M)(23.22M)(15.94M)
Total Debt518K10.53M9.16M6.58M631K
Net Debt(27.09M)(9.53M)4.57M5.13M(7.17M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$6.7M
Receivables$181.0K
Other Current$467.0K
Total Current Assets$7.4M
PP&E (Net)$936.0K
Goodwill$1.8M
Intangible Assets$879.0K
Long-term Investments$399.0K
Other Non-current$535.0K
Total Non-current Assets$4.5M
Total Assets$11.9M

Analysis

Selected assets total $11.9M for Latest. The largest visible component is Cash & Equivalents at $6.7M, about 56.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEF 14ADEF 14A filingNov 5, 2026
DEFA14ADEFA14A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
8-KCurrent reportNov 2, 2026

How much cash does NRXP have?

NRx Pharmaceuticals, Inc. (NRXP) reported $7.80M in cash and equivalents in fiscal 2025.

How much debt does NRXP carry?

NRx Pharmaceuticals, Inc. (NRXP) reported $631,000.00 of total debt, with net debt of -$7.17M.